<!DOCTYPE html>
<html lang="es">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Diabetes Mellitus â€” ClÃ­nica e HistologÃ­a</title>
<link href="https://fonts.googleapis.com/css2?family=Playfair+Display:wght@700;900&family=Source+Sans+3:wght@300;400;600;700&family=JetBrains+Mono:wght@400;600&display=swap" rel="stylesheet">
<style>
:root {
  --bg:#f4f0ec;--surface:#fff;--border:#ddd0c4;--text:#1a1410;--muted:#7a6a5a;
  --navy:#0d2137;
  --dm1:#8a1a1a;--dm1d:#8a1a1a14;
  --dm2:#1a5a8a;--dm2d:#1a5a8a14;
  --beta:#b07a10;--beta-d:#c49a2a18;
  --green:#1a6a3a;--green-d:#1a6a3a14;
  --purple:#6a3a8a;--purple-d:#6a3a8a14;
  --gold:#c49a2a;--gold-dim:#c49a2a18;
  --warm:#f5f0ea;
}
*{margin:0;padding:0;box-sizing:border-box;}
body{font-family:'Source Sans 3',sans-serif;background:var(--bg);color:var(--text);padding:2rem 1.5rem 4rem;background-image:repeating-linear-gradient(0deg,transparent,transparent 31px,#ddd0c428 31px,#ddd0c428 32px);}
header{text-align:center;margin-bottom:1.8rem;}
.badge{display:inline-flex;align-items:center;background:var(--navy);color:white;font-family:'JetBrains Mono',monospace;font-size:0.68rem;letter-spacing:0.12em;padding:0.35rem 1.2rem;border-radius:3px;margin-bottom:0.6rem;text-transform:uppercase;}
h1{font-family:'Playfair Display',serif;font-weight:900;font-size:clamp(1.5rem,4vw,2.5rem);color:var(--navy);line-height:1.1;}
.subtitle{font-family:'JetBrains Mono',monospace;font-size:0.7rem;color:var(--muted);letter-spacing:0.15em;text-transform:uppercase;margin-top:0.5rem;}
.wrap{max-width:1100px;margin:0 auto;}
.memo-box{border-radius:6px;padding:0.55rem 0.9rem;margin-top:0.7rem;border:1px solid var(--gold);background:var(--gold-dim);}
.memo-label{font-family:'JetBrains Mono',monospace;font-size:0.58rem;text-transform:uppercase;letter-spacing:0.15em;color:var(--gold);margin-bottom:0.2rem;}
.memo-text{color:var(--text);font-weight:700;font-size:0.8rem;line-height:1.5;}
.grid2{display:grid;grid-template-columns:1fr 1fr;gap:1.1rem;}
@media(max-width:750px){.grid2{grid-template-columns:1fr;}}
.full{grid-column:1/-1;}
.card{background:var(--surface);border:1px solid var(--border);border-radius:10px;overflow:hidden;box-shadow:0 2px 8px rgba(0,0,0,0.05);}
.card-head{padding:0.75rem 1.1rem;border-bottom:1px solid var(--border);display:flex;align-items:center;gap:0.6rem;}
.card-icon{font-size:1.1rem;flex-shrink:0;}
.card-title{font-family:'Playfair Display',serif;font-size:0.95rem;font-weight:700;flex:1;}
.card-body{padding:1rem 1.1rem;}

/* DEFINICIÃ“N BANNER */
.def-banner{background:var(--navy);border-radius:10px;padding:1rem 1.3rem;margin-bottom:1.2rem;display:flex;align-items:flex-start;gap:1rem;}
.def-icon{font-size:1.8rem;flex-shrink:0;}
.def-text{color:white;font-size:0.82rem;line-height:1.6;}
.def-text strong{color:#ffd090;}

/* DM CARDS */
.dm-card{background:var(--surface);border-radius:12px;overflow:hidden;border:2px solid;box-shadow:0 2px 10px rgba(0,0,0,0.06);}
.dm-head{display:flex;align-items:stretch;}
.dm-bar{width:6px;flex-shrink:0;}
.dm-icon{padding:1.1rem 0.9rem;display:flex;align-items:center;justify-content:center;flex-shrink:0;min-width:65px;font-size:2rem;}
.dm-info{padding:0.9rem 0.9rem 0.9rem 0;flex:1;}
.dm-type{font-family:'JetBrains Mono',monospace;font-size:0.6rem;text-transform:uppercase;letter-spacing:0.15em;font-weight:700;margin-bottom:0.15rem;}
.dm-name{font-family:'Playfair Display',serif;font-size:1.2rem;font-weight:900;line-height:1.1;margin-bottom:0.2rem;}
.dm-kw{font-family:'JetBrains Mono',monospace;font-size:0.65rem;font-weight:700;padding:0.18rem 0.6rem;border-radius:20px;display:inline-block;}
.dm-body{padding:0 1rem 1rem;}
.dm-section{margin-bottom:0.7rem;}
.dm-sec-label{font-family:'JetBrains Mono',monospace;font-size:0.58rem;text-transform:uppercase;letter-spacing:0.12em;font-weight:700;margin-bottom:0.35rem;display:flex;align-items:center;gap:0.3rem;}
.item-grid{display:grid;grid-template-columns:repeat(2,1fr);gap:0.35rem;}
@media(max-width:480px){.item-grid{grid-template-columns:1fr;}}
.item{background:var(--warm);border:1px solid var(--border);border-radius:5px;padding:0.45rem 0.6rem;border-left:3px solid;font-size:0.73rem;line-height:1.35;}
.item strong{display:block;font-size:0.75rem;margin-bottom:0.05rem;}

/* DM1 */
.dm1{border-color:var(--dm1);}
.dm1 .dm-bar{background:var(--dm1);}
.dm1 .dm-icon{background:var(--dm1d);}
.dm1 .dm-type,.dm1 .dm-name{color:var(--dm1);}
.dm1 .dm-kw{background:var(--dm1);color:white;}
.dm1 .dm-sec-label{color:var(--dm1);}
.dm1 .item{border-color:var(--dm1);}

/* DM2 */
.dm2{border-color:var(--dm2);}
.dm2 .dm-bar{background:var(--dm2);}
.dm2 .dm-icon{background:var(--dm2d);}
.dm2 .dm-type,.dm2 .dm-name{color:var(--dm2);}
.dm2 .dm-kw{background:var(--dm2);color:white;}
.dm2 .dm-sec-label{color:var(--dm2);}
.dm2 .item{border-color:var(--dm2);}

/* ISLOTES HISTOLOGÃA */
.celulas-grid{display:grid;grid-template-columns:repeat(4,1fr);gap:0.5rem;}
@media(max-width:600px){.celulas-grid{grid-template-columns:1fr 1fr;}}
.cel-card{border-radius:8px;overflow:hidden;border:1px solid;text-align:center;}
.cel-head{padding:0.65rem 0.4rem;}
.cel-symbol{font-size:1.4rem;margin-bottom:0.15rem;}
.cel-name{font-family:'JetBrains Mono',monospace;font-size:0.6rem;text-transform:uppercase;letter-spacing:0.08em;font-weight:700;}
.cel-pct{font-family:'Playfair Display',serif;font-size:1.1rem;font-weight:900;}
.cel-body{padding:0.45rem;background:white;font-size:0.68rem;color:var(--muted);line-height:1.3;}
.cb{border-color:var(--beta);}.cb .cel-head{background:var(--beta-d);}.cb .cel-name,.cb .cel-pct{color:var(--beta);}
.ca{border-color:var(--dm1);}.ca .cel-head{background:var(--dm1d);}.ca .cel-name,.ca .cel-pct{color:var(--dm1);}
.cd{border-color:var(--green);}.cd .cel-head{background:var(--green-d);}.cd .cel-name,.cd .cel-pct{color:var(--green);}
.cp{border-color:var(--purple);}.cp .cel-head{background:var(--purple-d);}.cp .cel-name,.cp .cel-pct{color:var(--purple);}

/* HISTOLOGÃA FASES */
.histo-strip{display:flex;gap:0;border-radius:8px;overflow:hidden;border:1px solid var(--border);}
.hs{flex:1;padding:0.6rem 0.5rem;text-align:center;border-right:1px solid var(--border);}
.hs:last-child{border-right:none;}
.hs-icon{font-size:1rem;margin-bottom:0.15rem;}
.hs-label{font-family:'JetBrains Mono',monospace;font-size:0.55rem;text-transform:uppercase;letter-spacing:0.06em;font-weight:700;margin-bottom:0.1rem;}
.hs-desc{font-size:0.62rem;color:var(--muted);line-height:1.2;}
@media(max-width:500px){.histo-strip{flex-direction:column;}.hs{border-right:none;border-bottom:1px solid var(--border);}.hs:last-child{border-bottom:none;}}

/* FÃRMACOS DM2 */
.farma-grid{display:grid;grid-template-columns:repeat(2,1fr);gap:0.4rem;}
.farma-item{background:var(--warm);border:1px solid var(--border);border-radius:6px;padding:0.5rem 0.65rem;border-left:3px solid;}
.farma-name{font-weight:700;font-size:0.76rem;margin-bottom:0.1rem;}
.farma-mec{font-size:0.68rem;color:var(--muted);line-height:1.3;}
.farma-adv{font-size:0.65rem;color:var(--dm1);margin-top:0.1rem;font-style:italic;}

/* COMPLICACIONES */
.comp-grid{display:grid;grid-template-columns:1fr 1fr;gap:0.5rem;}
.comp-block{background:var(--warm);border:1px solid var(--border);border-radius:7px;padding:0.65rem 0.75rem;}
.comp-label{font-family:'JetBrains Mono',monospace;font-size:0.58rem;text-transform:uppercase;letter-spacing:0.1em;font-weight:700;margin-bottom:0.35rem;}
.comp-list{display:flex;flex-direction:column;gap:0.2rem;}
.comp-item{font-size:0.73rem;display:flex;gap:0.35rem;line-height:1.3;}
.comp-item::before{content:'â–¸';flex-shrink:0;font-size:0.65rem;margin-top:0.1rem;}

/* TEST */
.tcard .card-head{background:var(--dm1d);border-bottom:2px solid var(--dm1);}
.tcard .card-title{color:var(--dm1);}
.qgrid{display:grid;grid-template-columns:repeat(auto-fit,minmax(270px,1fr));gap:0 1.4rem;}
.qb{padding:0.55rem 0;border-bottom:1px dashed var(--border);font-size:0.78rem;}
.qb:last-child{border-bottom:none;}
.qt{color:var(--muted);margin-bottom:0.2rem;line-height:1.4;}
.qt::before{content:'â“ ';}
.qa{font-weight:700;color:var(--dm1);display:flex;align-items:flex-start;gap:0.35rem;}
.qa::before{content:'â†’';color:var(--gold);font-weight:900;flex-shrink:0;}
.qn{font-size:0.66rem;color:var(--muted);margin-top:0.08rem;font-style:italic;}

.sec-divider{display:flex;align-items:center;gap:0.8rem;margin:1.5rem 0 0.8rem;}
.sec-divider div{flex:1;height:2px;background:var(--navy);opacity:0.12;}
.sec-divider span{font-family:'Playfair Display',serif;font-size:1.1rem;font-weight:900;color:var(--navy);white-space:nowrap;}
</style>
</head>
<body>

<header>
  <div class="badge">ğŸ©¸ EndocrinologÃ­a Â· FarmacologÃ­a</div>
  <h1>Diabetes Mellitus</h1>
  <p class="subtitle">ClÃ­nica Â· FarmacologÃ­a Â· HistologÃ­a Â· INGESA EnfermerÃ­a</p>
</header>

<div class="wrap">

  <!-- DEFINICIÃ“N -->
  <div class="def-banner">
    <span class="def-icon">ğŸ”¬</span>
    <div class="def-text">
      <strong>DefiniciÃ³n:</strong> Enfermedad metabÃ³lica crÃ³nica con <strong style="color:#ffd090">hiperglucemia sostenida</strong> por defecto de secreciÃ³n de insulina, de acciÃ³n de insulina o <strong style="color:#ffd090">ambos</strong>.
    </div>
  </div>

  <!-- DM1 + DM2 -->
  <div class="grid2">

    <!-- DM TIPO 1 -->
    <div class="dm-card dm1">
      <div class="dm-head">
        <div class="dm-bar"></div>
        <div class="dm-icon">ğŸ”´</div>
        <div class="dm-info">
          <div class="dm-type">Tipo 1</div>
          <div class="dm-name">Diabetes Mellitus 1</div>
          <span class="dm-kw">Autoinmune Â· Insulinodependiente</span>
        </div>
      </div>
      <div class="dm-body">
        <div class="dm-section">
          <div class="dm-sec-label">âš™ï¸ FisiopatologÃ­a</div>
          <div class="item" style="grid-column:1/-1">DestrucciÃ³n <strong>autoinmune</strong> de cÃ©lulas beta â†’ <strong>deficiencia absoluta</strong> de insulina â†’ hiperglucemia + lipÃ³lisis + cetogÃ©nesis<br><span style="font-size:0.68rem;color:var(--muted)">NiÃ±ez, adolescencia o adultos jÃ³venes Â· genÃ©tica + factores ambientales</span></div>
        </div>
        <div class="dm-section">
          <div class="dm-sec-label">ğŸ¤’ ClÃ­nica</div>
          <div class="item-grid">
            <div class="item"><strong>Inicio</strong> Agudo o subagudo (semanas)</div>
            <div class="item"><strong>Las 4 P</strong> Poliuria Â· Polidipsia Â· Polifagia Â· PÃ©rdida de peso</div>
            <div class="item"><strong>Otros</strong> Cansancio Â· visiÃ³n borrosa</div>
            <div class="item" style="border-color:#8a1a1a;background:#fff0f0"><strong style="color:var(--dm1)">âš ï¸ CAD debut</strong> VÃ³mitos Â· Kussmaul Â· aliento cetÃ³nico Â· alt. conciencia</div>
          </div>
        </div>
        <div class="dm-section">
          <div class="dm-sec-label">ğŸ’‰ Tratamiento</div>
          <div class="item-grid">
            <div class="item"><strong>Insulina obligatoria</strong> desde el diagnÃ³stico</div>
            <div class="item"><strong>Esquema basal-bolo</strong> Basal + rÃ¡pida antes de comidas</div>
            <div class="item" style="grid-column:1/-1"><strong>EducaciÃ³n:</strong> autocontrol glucÃ©mico Â· conteo de raciones Â· prevenciÃ³n de hipoglucemias</div>
          </div>
        </div>
      </div>
    </div>

    <!-- DM TIPO 2 -->
    <div class="dm-card dm2">
      <div class="dm-head">
        <div class="dm-bar"></div>
        <div class="dm-icon">ğŸ”µ</div>
        <div class="dm-info">
          <div class="dm-type">Tipo 2</div>
          <div class="dm-name">Diabetes Mellitus 2</div>
          <span class="dm-kw">Resistencia Â· DÃ©ficit relativo</span>
        </div>
      </div>
      <div class="dm-body">
        <div class="dm-section">
          <div class="dm-sec-label">âš™ï¸ FisiopatologÃ­a</div>
          <div class="item"><strong>Resistencia</strong> a insulina (mÃºsculo, hÃ­gado, adiposo) + <strong>deterioro progresivo</strong> secreciÃ³n beta<br><span style="font-size:0.68rem;color:var(--muted)">Obesidad central Â· sedentarismo Â· edad Â· s. metabÃ³lico Â· HF+</span></div>
        </div>
        <div class="dm-section">
          <div class="dm-sec-label">ğŸ¤’ ClÃ­nica</div>
          <div class="item-grid">
            <div class="item"><strong>Inicio insidioso</strong> AÃ±os asintomÃ¡tica</div>
            <div class="item"><strong>SÃ­ntomas</strong> Poliuria Â· polidipsia Â· infecciones repeticiÃ³n Â· mala cicatrizaciÃ³n</div>
            <div class="item" style="grid-column:1/-1"><strong>DiagnÃ³stico frecuente por complicaciones:</strong> cardiopatÃ­a isquÃ©mica Â· ictus Â· neuropatÃ­a Â· retinopatÃ­a Â· nefropatÃ­a</div>
          </div>
        </div>
        <div class="dm-section">
          <div class="dm-sec-label">ğŸ’Š FarmacologÃ­a â€” resumen examen</div>
          <div class="farma-grid">
            <div class="farma-item" style="border-color:var(--green);grid-column:1/-1">
              <div class="farma-name" style="color:var(--green)">â­ Metformina â€” 1Âª elecciÃ³n</div>
              <div class="farma-mec">â†“ producciÃ³n hepÃ¡tica glucosa Â· mejora sensibilidad perifÃ©rica Â· sin hipoglucemia Â· no sube peso</div>
              <div class="farma-adv">CI: IR avanzada Â· acidosis lÃ¡ctica Â· IH grave Â· hipoxia severa</div>
            </div>
            <div class="farma-item" style="border-color:var(--dm1)">
              <div class="farma-name" style="color:var(--dm1)">Sulfonilureas</div>
              <div class="farma-mec">Secretagogos: estimulan cÃ©lulas beta</div>
              <div class="farma-adv">âš ï¸ Hipoglucemia + aumento de peso</div>
            </div>
            <div class="farma-item" style="border-color:var(--dm2)">
              <div class="farma-name" style="color:var(--dm2)">iDPP-4</div>
              <div class="farma-mec">â†‘ incretinas Â· efecto moderado Â· bajo riesgo hipoglucemia</div>
            </div>
            <div class="farma-item" style="border-color:var(--purple)">
              <div class="farma-name" style="color:var(--purple)">aGLP-1</div>
              <div class="farma-mec">Inyectables Â· â†“ peso Â· buena opciÃ³n obesidad/alto riesgo CV</div>
            </div>
            <div class="farma-item" style="border-color:var(--beta)">
              <div class="farma-name" style="color:var(--beta)">iSGLT2</div>
              <div class="farma-mec">â†‘ glucosuria Â· beneficios CV y renales Â· â†“ peso</div>
            </div>
          </div>
        </div>
        <div class="memo-box" style="background:var(--dm2d);border-color:var(--dm2);">
          <div class="memo-label" style="color:var(--dm2)">ğŸ§  Insulina en DM2 â€” cuÃ¡ndo</div>
          <div class="memo-text" style="font-size:0.75rem">HbA1c â‰¥10% Â· glucemia â‰¥300 mg/dl Â· fracaso ADO Â· situaciÃ³n aguda (infecciÃ³n grave, cirugÃ­a, embarazo) â†’ <strong>mantener metformina</strong> al aÃ±adir insulina</div>
        </div>
      </div>
    </div>

  </div>

  <!-- COMPLICACIONES -->
  <div class="sec-divider"><div></div><span>âš¡ Complicaciones clave</span><div></div></div>
  <div class="comp-grid" style="max-width:1100px;margin:0 auto;">
    <div class="comp-block" style="border-left:4px solid var(--dm1)">
      <div class="comp-label" style="color:var(--dm1)">ğŸš¨ Agudas</div>
      <div class="comp-list">
        <div class="comp-item" style="color:var(--muted)"><span style="color:var(--dm1)">â–¸</span><span><strong>Hipoglucemia:</strong> sudor frÃ­o Â· temblor Â· ansiedad Â· alt. conciencia</span></div>
        <div class="comp-item" style="color:var(--muted)"><span style="color:var(--dm1)">â–¸</span><span><strong>CAD (DM1):</strong> hiperglucemia + acidosis metabÃ³lica + cetosis</span></div>
        <div class="comp-item" style="color:var(--muted)"><span style="color:var(--dm2)">â–¸</span><span><strong>Estado hiperosmolar (DM2):</strong> hiperglucemia extrema Â· sin cetosis Â· deshidrataciÃ³n</span></div>
      </div>
    </div>
    <div class="comp-block" style="border-left:4px solid var(--dm2)">
      <div class="comp-label" style="color:var(--dm2)">ğŸ”„ CrÃ³nicas</div>
      <div class="comp-list">
        <div class="comp-item" style="color:var(--muted)"><span style="color:var(--dm2)">â–¸</span><span><strong>Microvasculares:</strong> retinopatÃ­a Â· nefropatÃ­a (proteinuria/IRC) Â· neuropatÃ­a perifÃ©rica</span></div>
        <div class="comp-item" style="color:var(--muted)"><span style="color:var(--dm2)">â–¸</span><span><strong>Macrovasculares:</strong> coronaria Â· cerebrovascular Â· arterial perifÃ©rica</span></div>
        <div class="comp-item" style="color:var(--muted)"><span style="color:var(--dm2)">â–¸</span><span><strong>Pie diabÃ©tico:</strong> Ãºlceras Â· neuropatÃ­a Â· infecciÃ³n</span></div>
      </div>
    </div>
  </div>

  <!-- HISTOLOGÃA -->
  <div class="sec-divider"><div></div><span>ğŸ”¬ HistologÃ­a pancreÃ¡tica</span><div></div></div>

  <!-- CÃ‰LULAS ISLOTES -->
  <div class="card" style="margin-bottom:1.1rem;">
    <div class="card-head" style="background:var(--beta-d);border-bottom:2px solid var(--beta)">
      <span class="card-icon">ğŸŸ¡</span>
      <span class="card-title" style="color:var(--beta)">Islotes de Langerhans â€” cÃ©lulas principales</span>
    </div>
    <div class="card-body">
      <div style="font-size:0.77rem;color:var(--muted);margin-bottom:0.7rem;line-height:1.5;">NÃ³dulos endocrinos dispersos entre acinos exocrinos Â· muy vascularizados Â· rodeados de delgado tejido conectivo</div>
      <div class="celulas-grid">
        <div class="cel-card cb">
          <div class="cel-head"><div class="cel-symbol">Î²</div><div class="cel-name">Beta</div><div class="cel-pct">50â€“80%</div></div>
          <div class="cel-body"><strong>Centro</strong> del islote<br>Producen <strong>insulina</strong> (+ amilina)</div>
        </div>
        <div class="cel-card ca">
          <div class="cel-head"><div class="cel-symbol">Î±</div><div class="cel-name">Alfa</div><div class="cel-pct">5â€“20%</div></div>
          <div class="cel-body"><strong>Periferia</strong> del islote<br>Producen <strong>glucagÃ³n</strong></div>
        </div>
        <div class="cel-card cd">
          <div class="cel-head"><div class="cel-symbol">Î´</div><div class="cel-name">Delta</div><div class="cel-pct">â‰ˆ5%</div></div>
          <div class="cel-body">Dispersas<br>Producen <strong>somatostatina</strong></div>
        </div>
        <div class="cel-card cp">
          <div class="cel-head"><div class="cel-symbol">PP</div><div class="cel-name">PP / F</div><div class="cel-pct">â‰¤2%</div></div>
          <div class="cel-body">Periferia<br><strong>PolipÃ©ptido pancreÃ¡tico</strong></div>
        </div>
      </div>
    </div>
  </div>

  <div class="grid2">

    <!-- HISTOLOGÃA DM1 -->
    <div class="card">
      <div class="card-head" style="background:var(--dm1d);border-bottom:2px solid var(--dm1)">
        <span class="card-icon">ğŸ”´</span>
        <span class="card-title" style="color:var(--dm1)">DM1 â€” "Insulitis linfocitaria"</span>
      </div>
      <div class="card-body">
        <div style="background:#fff0f0;border:1px solid var(--dm1);border-radius:7px;padding:0.65rem 0.8rem;margin-bottom:0.7rem;font-size:0.78rem;line-height:1.5;">
          <strong style="color:var(--dm1)">LesiÃ³n tÃ­pica:</strong> infiltrado <strong>linfocitario</strong> en islotes (linfocitos T) â†’ destrucciÃ³n progresiva cÃ©lulas beta â†’ islotes con <strong>pÃ©rdida casi total de Î²</strong>, permanecen cÃ©lulas alfa
        </div>
        <div style="font-family:'JetBrains Mono',monospace;font-size:0.58rem;text-transform:uppercase;letter-spacing:0.1em;color:var(--dm1);margin-bottom:0.4rem;">Fases progresivas</div>
        <div class="histo-strip" style="border-color:var(--dm1)">
          <div class="hs" style="background:#fff8f8"><div class="hs-icon">âœ…</div><div class="hs-label" style="color:var(--dm1)">Normal</div><div class="hs-desc">Islote Ã­ntegro Â· beta presentes</div></div>
          <div class="hs"><div class="hs-icon">ğŸ”¸</div><div class="hs-label" style="color:var(--dm1)">Peri-insular</div><div class="hs-desc">Infiltrado linfocitario alrededor</div></div>
          <div class="hs"><div class="hs-icon">ğŸ”´</div><div class="hs-label" style="color:var(--dm1)">Intra-insular</div><div class="hs-desc">Infiltrado dentro del islote</div></div>
          <div class="hs" style="background:#fff0f0"><div class="hs-icon">â¬œ</div><div class="hs-label" style="color:var(--dm1)">AtrÃ³fico</div><div class="hs-desc">Sin beta Â· solo alfa</div></div>
        </div>
        <div class="memo-box" style="background:var(--dm1d);border-color:var(--dm1);margin-top:0.7rem;">
          <div class="memo-label" style="color:var(--dm1)">ğŸ§  DM1 â†’ las 3 "I"</div>
          <div class="memo-text" style="font-size:0.77rem"><span style="color:var(--dm1)">I</span>nsulitis Â· <span style="color:var(--dm1)">I</span>nmunitaria Â· <span style="color:var(--dm1)">I</span>slote sin beta</div>
        </div>
      </div>
    </div>

    <!-- HISTOLOGÃA DM2 -->
    <div class="card">
      <div class="card-head" style="background:var(--dm2d);border-bottom:2px solid var(--dm2)">
        <span class="card-icon">ğŸ”µ</span>
        <span class="card-title" style="color:var(--dm2)">DM2 â€” "Amiloide en islotes"</span>
      </div>
      <div class="card-body">
        <div style="background:#f0f4ff;border:1px solid var(--dm2);border-radius:7px;padding:0.65rem 0.8rem;margin-bottom:0.7rem;font-size:0.78rem;line-height:1.5;">
          <strong style="color:var(--dm2)">LesiÃ³n tÃ­pica:</strong> depÃ³sitos de <strong>amiloide</strong> (amilina/hIAPP) en islotes Â· menos inflamaciÃ³n que DM1
        </div>
        <div style="font-family:'JetBrains Mono',monospace;font-size:0.58rem;text-transform:uppercase;letter-spacing:0.1em;color:var(--dm2);margin-bottom:0.4rem;">EvoluciÃ³n estructural</div>
        <div class="histo-strip" style="border-color:var(--dm2)">
          <div class="hs" style="background:#f5f8ff"><div class="hs-icon">ğŸ“ˆ</div><div class="hs-label" style="color:var(--dm2)">Inicio</div><div class="hs-desc">Islotes <strong>aumentados</strong> de tamaÃ±o</div></div>
          <div class="hs"><div class="hs-icon">ğŸ”·</div><div class="hs-label" style="color:var(--dm2)">ProgresiÃ³n</div><div class="hs-desc">DepÃ³sitos de <strong>amiloide</strong></div></div>
          <div class="hs" style="background:#f0f4ff"><div class="hs-icon">ğŸ“‰</div><div class="hs-label" style="color:var(--dm2)">TardÃ­o</div><div class="hs-desc">â†“ masa beta Â· reemplazo amiloide</div></div>
        </div>
        <div style="background:var(--warm);border:1px solid var(--border);border-radius:6px;padding:0.55rem 0.75rem;margin-top:0.6rem;font-size:0.74rem;line-height:1.4;">
          <strong>Diferencia clave con DM1:</strong> <span style="color:var(--muted)">No hay insulitis Â· predominan depÃ³sitos amiloides Â· no linfocitos</span>
        </div>
        <div class="memo-box" style="background:var(--dm2d);border-color:var(--dm2);margin-top:0.7rem;">
          <div class="memo-label" style="color:var(--dm2)">ğŸ§  DM2 â†’ las 3 "A"</div>
          <div class="memo-text" style="font-size:0.77rem"><span style="color:var(--dm2)">A</span>miloide Â· <span style="color:var(--dm2)">A</span>milina Â· <span style="color:var(--dm2)">A</span>umento inicial islotes</div>
        </div>
      </div>
    </div>

  </div>

  <!-- TEST -->
  <div class="card tcard" style="margin-top:1.2rem;">
    <div class="card-head"><span class="card-icon">ğŸ¯</span><span class="card-title">Preguntas tipo test â€” Diabetes Mellitus</span></div>
    <div class="card-body"><div class="qgrid">
      <div class="qb">
        <div class="qt">Â¿CuÃ¡l es la lesiÃ³n histolÃ³gica tÃ­pica de la DM1?</div>
        <div class="qa"><strong>Insulitis linfocitaria</strong> â€” infiltrado de linfocitos T</div>
      </div>
      <div class="qb">
        <div class="qt">Â¿CuÃ¡l es la lesiÃ³n histolÃ³gica tÃ­pica de la DM2?</div>
        <div class="qa"><strong>DepÃ³sitos de amiloide</strong> (amilina/hIAPP) en islotes</div>
      </div>
      <div class="qb">
        <div class="qt">Â¿QuÃ© cÃ©lulas del islote se destruyen en la DM1?</div>
        <div class="qa">CÃ©lulas <strong>beta (Î²)</strong> â€” quedan principalmente las alfa</div>
      </div>
      <div class="qb">
        <div class="qt">Â¿CuÃ¡l es el fÃ¡rmaco de elecciÃ³n inicial en DM2?</div>
        <div class="qa"><strong>Metformina</strong> â€” no causa hipoglucemia Â· no sube peso</div>
      </div>
      <div class="qb">
        <div class="qt">Â¿CuÃ¡l es el efecto adverso principal de las sulfonilureas?</div>
        <div class="qa"><strong>Hipoglucemia</strong> y aumento de peso</div>
      </div>
      <div class="qb">
        <div class="qt">Â¿QuÃ© complicaciÃ³n aguda es tÃ­pica de DM1?</div>
        <div class="qa"><strong>Cetoacidosis diabÃ©tica (CAD)</strong> â€” hiperglucemia + acidosis + cetosis</div>
      </div>
      <div class="qb">
        <div class="qt">Â¿QuÃ© cÃ©lulas producen glucagÃ³n en el islote?</div>
        <div class="qa">CÃ©lulas <strong>alfa (Î±)</strong> â€” en la periferia del islote</div>
      </div>
      <div class="qb">
        <div class="qt">Â¿CuÃ¡ndo se indica insulina en DM2?</div>
        <div class="qa">HbA1c â‰¥10% Â· glucemia â‰¥300 Â· fracaso ADO Â· situaciÃ³n aguda</div>
        <div class="qn">Se mantiene metformina al aÃ±adir insulina</div>
      </div>
    </div></div>
  </div>

</div>
</body>
</html>
